Stalopam 15mg Tablet
Introduction
Stalopam 15mg Tablet is a prescription medicine belonging to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). It is commonly prescribed for the treatment of depression, generalized anxiety disorder (GAD), and other mood-related conditions. By increasing serotonin levels in the brain, it helps improve mood, relieve anxiety, and enhance emotional stability.
Benefits
• Provides relief from symptoms of depression
• Reduces excessive worry, fear, and restlessness in anxiety disorders
• Improves sleep quality and energy levels
• Helps restore normal daily functioning and quality of life
• Safe and effective for long-term management when used under medical supervision
Side Effects
• Common: Nausea, dizziness, headache, sweating, dry mouth, constipation, fatigue
• Less common: Insomnia, sexual problems, weight changes, increased heart rate
• Rare but serious: Suicidal thoughts, severe mood changes, seizures, allergic reactions
Most side effects are mild and temporary. Contact your doctor if they persist or worsen.
How to Use
• Take the tablet as directed by your doctor, usually once daily
• Can be taken with or without food
• Take at the same time each day for best results
• Do not stop suddenly without medical advice to avoid withdrawal symptoms
What to Avoid
• Avoid alcohol as it can increase drowsiness and dizziness
• Do not take with other antidepressants or medicines that affect serotonin without medical advice
• Avoid driving or operating heavy machinery if you feel drowsy or dizzy
• Do not exceed the prescribed dosage
Precautions
• Inform your doctor if you have liver or kidney disease, seizures, heart problems, or bleeding disorders
• Not suitable for individuals with a history of bipolar disorder unless monitored closely
• Pregnant or breastfeeding women should use only if prescribed by a doctor
• Regular check-ups are important to monitor mood, progress, and side effects
• Store in a cool, dry place, away from direct sunlight and children




Reviews
There are no reviews yet.